Analysts: Astex Pharmaceuticals Inc (ASTX.OQ)

ASTX.OQ on NASDAQ Stock Exchange Global Select Market

5.54USD
4:00pm EDT
Price Change (% chg)

$0.31 (+5.93%)
Prev Close
$5.23
Open
$5.35
Day's High
$5.59
Day's Low
$5.28
Volume
273,853
Avg. Vol
394,279
52-wk High
$6.94
52-wk Low
$2.15

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.08 December 1 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 0 0 0
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 3 15.01 19.32 11.80 --
Quarter Ending Dec-13 3 7.32 9.75 5.20 --
Year Ending Dec-13 4 58.66 66.25 55.00 61.02
Year Ending Dec-14 4 27.53 42.50 18.30 24.40
Earnings (per share)
Quarter Ending Sep-13 3 -0.08 -0.03 -0.11 --
Quarter Ending Dec-13 3 -0.15 -0.13 -0.18 --
Year Ending Dec-13 4 -0.26 -0.19 -0.34 -0.20
Year Ending Dec-14 4 -0.63 -0.52 -0.76 -0.70

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 18.47 22.09 3.62 19.62
Quarter Ending Dec-12 22.90 24.06 1.16 5.07
Quarter Ending Mar-12 17.97 22.02 4.05 22.53
Quarter Ending Dec-11 20.79 21.20 0.41 1.99
Quarter Ending Sep-11 16.12 16.95 0.82 5.11
Earnings (per share)
Quarter Ending Mar-13 -0.05 0.01 0.06 -118.18
Quarter Ending Dec-12 0.00 0.05 0.05 0.00
Quarter Ending Jun-12 -0.07 0.01 0.08 -114.29
Quarter Ending Mar-12 -0.02 0.01 0.03 -150.00
Quarter Ending Dec-11 -0.01 0.00 0.01 -100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 15.01 15.01 12.85 12.85 --
Quarter Ending Dec-13 7.32 7.32 6.10 6.10 --
Year Ending Dec-13 58.66 58.66 56.13 56.13 61.02
Year Ending Dec-14 27.53 27.53 27.27 25.85 24.40
Earnings (per share)
Quarter Ending Sep-13 -0.08 -0.08 -0.10 -0.10 --
Quarter Ending Dec-13 -0.15 -0.15 -0.16 -0.16 --
Quarter Ending Dec-13 -0.26 -0.26 -0.28 -0.28 -0.20
Quarter Ending Dec-14 -0.63 -0.63 -0.62 -0.64 -0.70

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$69.00
Provider: Wright Reports
$472.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks